cTnI Rapid Quantitative Test

Product Introduction

This product is used to detect the concentration of cardiac troponin I in human plasma or whole blood. The creatine troponin complex, consisting of cardiac muscle creatine troponin I (cTnI), troponin T (TnT), and troponin C (TnC), can adjust the interaction between actin and myosin. The concentration of cTnI is pretty low in healthy human blood; However, when acute myocardium infarction occurs, cTnI is released into the blood quickly, which leads to the rapid increase of cTnI concentration in hours and lasts 6 to 10 days. Therefore, blood cTnI concentration is regarded as a marker for myocardial infarction[1- 3].

Product Specification

Advantages

ICU, Respiratory Medicine, Emergency Department, Cardiology, Laboratory, emergency care

Reference：
1. Le Tao. The clinical application and evaluation of the Triad rapid diagnosis to myocardial infarction. Journal of Chinese Clinical Medicine. 2005, 140: 15239- 15240.
2.Albert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction.
3.Bernadette Cummins B. Sc. Margaret Lucy Auckland B. Sc. Peter Cummins Ph.D. Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction[J]. Journal of American Heart. 1987, 113:1333-1344.